Product
CH505TF gp120
1 clinical trial
1 indication
Indication
HIV InfectionsClinical trial
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected InfantsStatus: Active (not recruiting), Estimated PCD: 2024-08-20